IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,942,926 | +232.1% | 249,382 | +283.7% | 0.01% | +250.0% |
| Q2 2023 | $3,897,400 | +43070.1% | 65,000 | -64.4% | 0.00% | -60.0% |
| Q1 2023 | $9,028 | -60.0% | 182,603 | -53.9% | 0.01% | -61.5% |
| Q4 2022 | $22,584 | -99.7% | 395,728 | +153.4% | 0.01% | +225.0% |
| Q3 2022 | $7,331,000 | +268.8% | 156,182 | +193.1% | 0.00% | +300.0% |
| Q2 2022 | $1,988,000 | +105.2% | 53,278 | +64.4% | 0.00% | 0.0% |
| Q1 2022 | $969,000 | -72.1% | 32,400 | -65.5% | 0.00% | -50.0% |
| Q3 2021 | $3,478,000 | -13.6% | 93,812 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $4,027,000 | -53.6% | 103,121 | -49.4% | 0.00% | -66.7% |
| Q1 2021 | $8,670,000 | – | 203,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |